Recent News

March 2023

Dr. Silverman and collaborators publish their study, "Downregulation of Hsp90 and the antimicrobial peptide Mtk suppresses poly(GR)-induced neurotoxicity in C9ORF72-ALS/FTD," in Neuron. Read more.

Previous headlines

December 2022: Dr. Silverman, along with collaborators from the Duke University School of Medicine and the Shanghai Institute of Biochemistry and Cell Biology, recently had their work, “Retrotransposon Activation During Drosophila Metamorphosis Conditions Adult Antiviral Responses,” published in Nature Genetics. Read more.

October 2022: Scientists in the Silverman Lab, Program in Innate Immunity publish new findings on the role of transporter SLC46A2 on psoriatic skin inflammation. Read more.

July 2022: We are thrilled that campus life has started to return to normal and we are able to welcome interns back to our lab this summer, for the first time since 2019! Joining us in the Silverman Lab are Tess Keppel and Zubin Nawab. 

March 2022: Researchers in the Silverman lab have published novel study “Leishmania amazonensis sabotages host cell SUMOylation for intracellular survival.” New findings in pre-print on bioRxiv

August 2021: Dr. Silverman received competing renewal for the NIH-funded T32 training grant: Innate Immunity Training Program (IITP) at UMass Chan Medical School, for which he is the Program Director. Learn more about the IITP.